Moreover, hormone- and carcinogen-treated MMTV-RANK and wild-type mice treated subcutaneously with the RANK inhibitor, RANK FC, have reduced epithelial proliferation, precancerous lesions, and reduced incidence of breast cancer (9). The gene discussed is TNFRSF11A; the disease is breast carcinoma.